United States · Investor

Prolog Ventures

Last cheque observed May 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund $26M, Jul 2013VC firmWebsite unconfirmed

SeedSeries ASeries BNetwork SecuritySecurityVenture Capital & Private Equity

Cheques on record
0%of best year0cheques in 12 months, 41 on record
Since the last cheque2722days00hrs00min00sec
Median round$13MCheque size, as they say$1.0M – $7.0MRounds led1 of 41Sole investor4 roundsExits3 from the portfolioMostly inUnited States, 100%
Pitch Prolog Ventures

Prolog Ventures highlights

  1. 01

    41 rounds on record

  2. 02

    Mostly Venture and Series A: 57% of its rounds

  3. 03

    Sole investor in 4 rounds, median $9.3M

  4. 04

    3 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
$1.0M – $7.0M as they say
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
Network SecuritySecurityVenture Capital & Private Equity
Based in
St. Louis, United States
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first41 appearances

  1. 2019

    1 round

  2. May
    BioClarityUS · Wwd$13MLed
  3. 2018

    2 rounds

  4. Nov
    CoverCressBridge · Agfundernews$2.0MWith 5 others
  5. Jan
    CareDoxSeries B · US · FinSMEs$16MWith 4 others
  6. 2017

    2 rounds

  7. Mar
    Benson Hill BiosystemsSeries B · US · FinSMEs$25MWith 10 others
  8. Mar
    CareDoxSeries A · US · FinSMEs$6.4MWith 2 others
  9. 2015

    5 rounds

  10. Oct
    IntellicytVenture · US$7.4MWith 3 others
  11. Sept
    Veran Medical TechnologiesVenture · US$42MWith 5 others
  12. Aug
    Benson Hill BiosystemsSeries A · US$7.3MWith 5 others
  13. Jun
    NeuroLutionsVenture · US$1.1MWith 2 others
  14. May
    EndoStimSeries E · US$2.5MSole investor
  15. 2014

    4 rounds

  16. Oct
    Veran Medical TechnologiesVenture · US$12MSole investor
  17. Sept
    AirXpandersSeries E · US$1.0MWith 3 others
  18. Jul
    Veran Medical TechnologiesDebt · US$6.5MSole investor
  19. May
    Spindrift BeverageVenture · US$2.0MWith 3 others
  20. 2013

    5 rounds

  21. Jun
    SingulexSeries G · US · bizjournals.com$15MWith 4 others
  22. Jun
    EndoStimSeries D · US · bizjournals.com$14MWith 2 others
  23. Jun
    AirXpandersSeries E · US · t.co$9.0MWith 3 others
  24. May
    IntellicytVenture · US · finsmes.com$8.0MWith 3 others
  25. Feb
    AkerminSeries A · US · bizjournals.com$1.5MWith 2 others
  26. 2012

    5 rounds

  27. Apr
    AirXpandersSeries D · US$11MWith 4 others
  28. Mar
    SingulexSeries F · US · sec.gov$15MWith 2 others
  29. Jan
    AirXpandersSeries D · US · researchviews.com$1.1MWith 2 others
  30. Jan
    AirXpandersGrowth · US$10MWith 4 others
  31. Jan
    The Nest CollectiveVenture · US$500KWith 2 others
  32. 2011

    1 round

  33. Mar
    VenitiSeries A · US · bizjournals.com$14MWith 2 others
  34. 2009

    1 round

  35. Feb
    DivergenceSeries C · US · cleantech.com$12MWith 2 others
  36. 2008

    2 rounds

  37. May
    AsoyiaVenture · US$4.0MWith 1 other
  38. Jan
    CS-KeysSeries A · US · ceresventurefund.com$6.3MWith 4 others
  39. 2007

    4 rounds

  40. Nov
    AkerminSeries A · US · akermin.com$5.0MWith 3 others
  41. Sept
    ChlorogenVenture · US$15MWith 4 others
  42. Jun
    SingulexSeries D · US · venturebeat.com$19MWith 3 others
  43. Jun
    Dreamerz FoodsSeries B · US · deals.venturebeat.com$10MWith 6 others
  44. 2006

    5 rounds

  45. Dec
    AirXpandersVenture · US$4.0MWith 1 other
  46. Nov
    Natural DentistSeries B · USUndisclosedWith 3 others
  47. Jul
    Travanti PharmaSeries B · US$7.5MWith 1 other
  48. Jul
    SingulexSeries C · US$9.3MWith 3 others
  49. Jan
    EraGen BiosciencesSeries A · US · eragen.com$12MWith 3 others
  50. 2005

    2 rounds

  51. Aug
    ChlorogenSeries B · US · bizjournals.com$6.0MWith 3 others
  52. Feb
    Brand New BrandsSeries A · US$15MWith 3 others
  53. 2004

    2 rounds

  54. Dec
    ZystorSeries A · US$8.5MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration4 named

BLBrian L ClevingerManaging Director of General PartneriFiling they signed
GJGreg JohnsonManaging Director of General PartneriFiling they signed
IBIlya B NykinManaging Director of General PartneriFiling they signed
JSJohn SteuartManaging Director of General PartneriFiling they signed

We also hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$2.8Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Prolog Ventures HL II, LLC
SEC number
CRD 170338

Exits from the portfolio

Companies it backed that were later bought or listed3 in all

EraGen BiosciencesBought by Luminex$34MJun 2011
DivergenceBought by MonsantoUndisclosedFeb 2011
ZystorBought by BioMarin Pharmaceutical$115MAug 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Prolog Ventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Prolog Ventures put money into.

Quick answers about Prolog Ventures

What does Prolog Ventures invest in?

Prolog Ventures invests most often at Venture and Series A (57% of the rounds on record), in sectors such as Network Security, Security and Venture Capital & Private Equity.

How active is Prolog Ventures?

41 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in May 2019.

What has Prolog Ventures invested in recently?

Its most recent investments on record: BioClarity (Undisclosed round, May 2019), CoverCress (Bridge, Nov 2018) and CareDox (Series B, Jan 2018).

How big are Prolog Ventures's cheques?

The median round it joins is $13M. It says it writes cheques of $1.0M to $7.0M.

Does Prolog Ventures lead rounds?

Sometimes: it led 1 of its 41 investments on record (2%).

Where does Prolog Ventures invest?

Most of the companies it backs are in the United States (100%).

Is Prolog Ventures investing now?

No investments in the last 12 months; the latest was in May 2019.

Who does Prolog Ventures invest alongside?

Most often Burrill & Company (6 rounds together), GBS Ventures (5 rounds together) and Vivo Ventures (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it